Multivessel vs. culprit-only percutaneous coronary intervention strategy in older adults with acute myocardial infarction

Engstrøm, 2015, Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3 - PRIMULTI): an open-label, randomised controlled trial, Lancet, 386, 665, 10.1016/S0140-6736(15)60648-1 Smits, 2017, Fractional flow reserve–guided multivessel angioplasty in myocardial infarction, N Engl J Med, 376, 1234, 10.1056/NEJMoa1701067 Mehta, 2019, Complete revascularization with multivessel PCI for myocardial infarction, N Engl J Med, 381, 1411, 10.1056/NEJMoa1907775 Sardella, 2016, Single-staged compared with multi-staged PCI in multivessel NSTEMI patients: the SMILE trial, J Am Coll Cardiol, 67, 264, 10.1016/j.jacc.2015.10.082 Ibanez, 2017, ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST -segment elevation – Web Addenda The Task Force for the management of acute myocardial infarction, Eur Heart J, 1 Collet, 2020, 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation, Eur Heart J, 42, 10.1093/eurheartj/ehaa575 Lawton, 2022, 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the american college of cardiology/american heart association joint committee on clinical practice guidelines, Circulation, 145, e18 Morici, 2022, Management of acute coronary syndromes in older adults, Eur Heart J, 43, 1542, 10.1093/eurheartj/ehab391 Crimi, 2020, Clinical impact of valvular heart disease in elderly patients admitted for acute coronary syndrome: insights from the elderly-ACS 2 study, Can J Cardiol, 36, 1104, 10.1016/j.cjca.2019.11.014 Montalto, 2022, Optimal P2Y12 inhibition in older adults with acute coronary syndromes: a network meta-analysis of randomized controlled trials, Eur Heart J Cardiovasc Pharmacother, 8, 20, 10.1093/ehjcvp/pvaa101 Savonitto S., Servi S De, Sonia A.,  et al. Early aggressive vs . initially conservative treatment in elderly patients with non-ST-elevation acute coronary syndrome: the Italian Elderly ACS study. 2008. De Belder A., De La J.M., Hernandez T., et al. A prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians The XIMA trial (xience or vision stents for the management of angina in the elderly). doi:10.1016/j.jacc.2013.10.053. Savonitto, 2018, Comparison of reduced-dose prasugrel and standard-dose clopidogrel in elderly patients with acute coronary syndromes undergoing early percutaneous revascularization, Circulation, 137, 2435, 10.1161/CIRCULATIONAHA.117.032180 de Belder, 2020, Revascularisation or medical therapy in elderly patients with acute anginal syndromes (RINCAL) A Randomised Trial, EuroIntervention Thygesen, 2007, Universal definition of myocardial infarction, Eur Heart J, 28, 2525, 10.1093/eurheartj/ehm355 Thygesen, 2012, Third universal definition of myocardial infarction, Eur Heart J, 33, 2551, 10.1093/eurheartj/ehs184 Stuart, 2010, Matching methods for causal inference: a review and a look forward, Stat Sci, 25, 1, 10.1214/09-STS313 Kleinbaum, 2010 Omer, 2021, Multivessel versus culprit-vessel percutaneous coronary intervention in patients with non–st-segment elevation myocardial infarction and cardiogenic shock, JACC Cardiovasc Interv, 14, 1067, 10.1016/j.jcin.2021.02.021 Lévesque, 2010, Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes, BMJ, 340, b5087, 10.1136/bmj.b5087 Van Der Weele, 2017, Sensitivity analysis in observational research: introducing the E-Value, Ann Intern Med, 167, 268, 10.7326/M16-2607 Paradies V., Waldeyer C., Laforgia P.L., Clemmensen P., Smits P.C. Completeness of revascularisation in acute coronary syndrome patients with multivessel disease. EuroIntervention. 25AD;17(3):193–201. https://eurointervention.pcronline.com/article/completeness-of-revascularisation-in-acute-coronary-syndrome-patients-with-multivessel-disease. Gaba, 2021, Complete versus incomplete coronary revascularization: definitions, assessment and outcomes, Nat Rev Cardiol, 18, 155, 10.1038/s41569-020-00457-5 Rosner, 2012, Impact of the presence and extent of incomplete angiographic revascularization after percutaneous coronary intervention in acute coronary syndromes: the acute catheterization and urgent intervention triage strategy (ACUITY) trial, Circulation, 125, 2613, 10.1161/CIRCULATIONAHA.111.069237 Rashid, 2019, Temporal trends and inequalities in coronary angiography utilization in the management of non-ST-Elevation acute coronary syndromes in the U.S, Sci Rep., 9, 1, 10.1038/s41598-018-36504-y Montalto, 2020, Bleeding risk prediction in elderly patients managed invasively for acute coronary syndromes: external validation of the PRECISE-DAPT and PARIS scores, Int J Cardiol, 328, 22, 10.1016/j.ijcard.2020.11.065 Bendz, 2020, Acute coronary syndromes in older patients: does older age matter?, Lancet, 396, 585, 10.1016/S0140-6736(20)31317-9 NICOR. Myocardial Ischaemia/MINAP (Heart Attack audit). 2020. https://www.nicor.org.uk/national-cardiac-audit-programme/myocardial-ischaemia-minap-heart-attack-audit/. Shanmugam, 2015, An overview of PCI in the very elderly, J Geriatr Cardiol, 12, 174 Gaudino, 2020, Overall and cause-specific mortality in randomized clinical trials comparing percutaneous interventions with coronary bypass surgery: a meta-analysis, JAMA Intern Med, 180, 1638, 10.1001/jamainternmed.2020.4748 Bainey, 2014, Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis, Am Heart J, 167, 1, 10.1016/j.ahj.2013.09.018 Tegn, 2016, Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial, Lancet, 387, 1057, 10.1016/S0140-6736(15)01166-6 Biscaglia, 2020, Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: rationale and design of the FIRE trial, Am Heart J, 229, 100, 10.1016/j.ahj.2020.08.007 Rymer, 2019, Opportunities for enhancing the care of older patients with ST-elevation myocardial infarction presenting for primary percutaneous coronary intervention: rationale and design of the SAFE-STEMI for Seniors trial, Am Heart J, 218, 84, 10.1016/j.ahj.2019.09.014 Balbi, 2022, Culprit lesion detection in patients presenting With non-ST elevation acute coronary syndrome and multivessel disease, Cardiovasc Revascularization Med, 35, 110, 10.1016/j.carrev.2021.03.019 Gimbel, 2020, Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial, Lancet, 395, 1374, 10.1016/S0140-6736(20)30325-1